---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-086624"
form_type: "8-K"
ticker: "ISPC"
cik: "0001558569"
company_name: "iSpecimen Inc."
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T13:22:05.522534+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# iSpecimen Q2 revenue down 31% to $1.63M; net loss widens to $3.5M

## Summary
- Revenue of $1.63M (Q2 2023), down 31% YoY from $2.34M; net loss $3.5M ($0.39 per share) vs $2.6M ($0.30) in Q2 2022.
- Cash + investments $8.2M at June 30, down from $15.3M at Dec 31, 2022 due to operating spend and technology investments.
- Unique customer organizations up 22% YoY to 534; supplier organizations up 7.5% to 230.
- CEO cites industry-wide funding slowdown; backlog increased in Q2, expects stronger Q3 2023 results.
- New growth initiatives: sequencing pilot complete, embedded coordinators at supplier sites, remnant line reboot.

## SEC filing metadata
- accession: 0001104659-23-086624
- form_type: 8-K
- ticker: ISPC
- cik: 0001558569
- company_name: iSpecimen Inc.
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1558569/000110465923086624/0001104659-23-086624-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1558569/000110465923086624/tm2322620d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-086624
- JSON: https://secwatch.observer/filing/0001104659-23-086624.json
- Plain text: https://secwatch.observer/filing/0001104659-23-086624.txt

## Key facts
- Earnings Releases
  iSpecimen Inc. reported the six months ended June 30, 2023 results: revenue approximately $4.6 million, net income approximately $5.9 million, EPS $(0.66) per share.
  - Period: the six months ended June 30, 2023
  - Revenue: approximately $4.6 million
  - Net income: approximately $5.9 million
  - EPS: $(0.66) per share
  - Result: reported results
  source text: both our top and bottom-line results,” concluded Curley. Q2 2023 Financial Results & Recent Operational Highlights · Revenue of $1.63 million for the three month period and $4.6 million for the six month period of 2023 compared to $2.34 million for the three month period and $4.9 million for the six month period of 2022. · Unique supplier organizations under
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465923086624/0001104659-23-086624-index.htm
- Earnings Releases
  iSpecimen Inc. reported second quarter of 2023 results: revenue approximately $1.63 million, net income approximately $3.5 million, EPS $(0.39) per share.
  - Period: second quarter of 2023
  - Revenue: approximately $1.63 million
  - Net income: approximately $3.5 million
  - EPS: $(0.39) per share
  - Result: reported results
  source text: supplier and customer base, we expect to build both our top and bottom-line results,” concluded Curley. Q2 2023 Financial Results & Recent Operational Highlights · Revenue of $1.63 million for the three month period and $4.6 million for the six month period of 2023 compared to $2.34 million for the three month period and $4.9 million for the six month period of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465923086624/0001104659-23-086624-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.